Treatment of polycystic ovary syndrome with insulin-lowering agents

Author： Wang Ping   Streicher Patricia   Glueck Charles J  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.8, 2002-08, pp. : 1177-1189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome

By Katsiki Niki   Georgiadou Eleni   Hatzitolios Apostolos I.  

Drugs, Vol. 69, Iss. 11, 2009-07 ,pp. : 1417-1431

Adis International

Access to resources Recommend Favorite

Insulin-sensitisers in the treatment of polycystic ovary syndrome

By Teede Helena J   Meyer C   Norman RJ  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2419-2427

Informa Healthcare

Access to resources Recommend Favorite

Targeting insulin sensitivity in the treatment of polycystic ovary syndrome

By Pasquali Renato   Gambineri Alessandra  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 10, 2009-10 ,pp. : 1205-1226

Informa Healthcare

Access to resources Recommend Favorite

Insulin Resistance and Polycystic Ovary Syndrome

By  

Current Pharmaceutical Design, Vol. 22, Iss. 36, 2016-11 ,pp. : 5526-5534

Bentham Science Publishers

Access to resources Recommend Favorite

Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?

By Cheang Kai I   Nestler John E  

Reproductive BioMedicine Online, Vol. 8, Iss. 4, 2004-04 ,pp. : 440-447

Reproductive Healthcare Ltd

Access to resources Recommend Favorite